1. India Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Shree Pacetronix Limited

Shree Pacetronix Limited

BBSE:SHREEPAC
167.95
INR
+8.50
(+5.33%)
8.74EPS
14.71P/E
490.09MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
21.28
18.35
20.68
19.29
18.9
20.23
24.35
21
25.64
56.27
61.23
46.68
59.6
58.19
Basic EPS, GAAP
0.64
-0.17
-0.24
-0.9
0.37
0.39
0.66
0.15
2.17
9.06
9.33
2.08
8.66
8.88
Free Cash Flow per Basic Share
1.68
-0.41
3.22
-1.46
1.74
-2.59
2.24
0.91
3.76
1.28
-0.04
-2.01
4.66
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
15.18
14.91
14.68
13.77
14.45
14.84
15.5
15.65
17.82
26.88
36.21
38.29
48.3
- -
Tangible Book Value per Share
13.36
13.55
13.77
13.33
14.16
14.57
15.24
15.4
17.57
26.64
35.97
38.06
47.83
- -
Basic Weighted Avg Shares
4
4
4
4
4
4
4
4
4
4
4
4
4
4
Sales/Revenue/Turnover
77
66
74
69
68
73
88
76
92
203
220
168
216
212
Operating Margin (%)
10.51
4.05
4.11
-1.47
7.89
5.67
8.86
7.71
13.88
24.62
22.38
9.11
21.14
21.36
Depreciation Expense
6
8
8
7
4
4
5
5
5
6
- -
8
7
7
Net Income, GAAP
2
-1
-1
-3
1
1
2
1
8
33
34
7
31
32
Effective Tax Rate (%)
33.15
- -
- -
- -
30.24
44.44
32.89
59.82
26.37
29.45
27.35
28.1
25.39
25.39
Profit Margin (%)
3
-0.91
-1.15
-4.67
1.95
1.94
2.71
0.7
8.46
16.09
15.24
4.46
14.53
15.27
Working Capital
21
23
27
22
28
25
16
16
20
43
69
83
124
- -
LT Debt
1
2
2
5
9
12
6
7
6
4
5
4
3
- -
Total Equity
55
54
53
50
52
53
56
56
64
97
130
138
181
- -
Return on Invested Capital (%)
2.96
- -
- -
- -
4.42
3.43
5.11
1.93
9.9
29.09
21.97
5.72
16.63
- -
Return on Capital (%)
6.74
- -
- -
- -
4.23
3.52
5.28
2.1
10.76
32.22
24.82
6.46
17.39
- -
Return on Common Equity (%)
4.29
-1.11
-1.6
-6.34
2.61
2.68
4.34
0.95
12.96
40.52
29.58
5.59
19.72
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
24
- -
LT Borrowings
- -
3
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
697
343
490

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
196
- -
Cash, Cash Equivalents & STI
- -
15
- -
Accounts Receivable, Net
- -
106
- -
Inventories
- -
48
- -
Total Current Liabilities
- -
72
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
24
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.34%
27.31%
31.4%
Free Cash Flow
397.98%
967.84%
-333.26%
Net Income, GAAP
206.85%
386.43%
319.22%
Sales/Revenue/Turnover
16.03%
31.07%
28.77%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
49
40
36
43
168
2026
53
66
43
54
216
2027
49
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.03
0.09
-0.31
1.26
2.08
2026
1.85
3.64
0.16
3.06
8.66
2027
2.02
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Atul Kumar Sethi
Full Time Employees
132
Sector
Health technology
Industry
Medical specialties
Address
Plot No. 15, Industrial Area Dhar MP India 454775
IPO Date
Jun 8, 1993
Website
pacetronix.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Shree Pacetronix Limited Shree Pacetronix Limited manufactures and sells implantable cardiac pacemakers and related medical devices through its subsidiary Shree Coratomic Limited, operating primarily in the cardiac rhythm management segment for healthcare providers and patients requiring anti-bradycardia treatments in India and internationally. The company produces a range of single and dual chamber pacemakers including models such as Ventralite 940+, Tiranga, Pinnacle-8820, Tiranga-302, Pinnacle-R-SSIR-Model-29, Trinity-R, Smart-E, Charak DDDR, and Indus I SSB; pacing leads encompassing Atrial J-Bipolar Lead-3851-VB, IS1 Bipolar Lead 3851 VB, Screw-in Lead P12, and Zeus-1; and pacing system analyzers featuring dual chamber models with operating modes like VVI, VOO, AAI, AOO, DOO, DDD, VDD, and DAI, supporting basic rates from 30 to 140 PPM, output amplitudes up to 12V, and sensitivity thresholds for atrium and ventricle. Incorporated on January 11, 1988, as a private limited company and converted to public limited status in 1993, Shree Pacetronix Limited is headquartered in Pithampur, Madhya Pradesh, India, and listed on the Bombay Stock Exchange with approximately 5500 shareholders. In recent developments, the company received INR 10.65 million in funding in November 2025 with participation from Akash Sethi acquiring a 7.71% equity stake; issued and allotted equity shares and warrants via preferential issue; reappointed Atul Kumar Sethi as Managing Director; and faces an open offer from Akash Sethi to acquire up to 975,000 shares representing 26% of expanded share capital at INR 100 per share, opening October 31, 2025, with the Independent Directors Committee deeming the price fair and reasonable as of October 2025.